Showing results (221-230 of 447) with videos related to

Sort By:
Pageof 45
Thoracic Cancer|February 21, 2020
Number of metastatic organs negatively affects the treatment sequence in patients with EGFR-TKI failureTakaaki Mizuno, Hidehito Horinouchi, Sho Watanabe, et al.
Translational Lung Cancer Research|August 14, 2023
Distinct metastatic spread and progression patterns in patients treated with crizotinib for ROS1- and ALK-rearranged non-small cell lung cancer: a single-center retrospective studyTomoaki Nakamura, Tatsuya Yoshida, Yuki Takeyasu, et al.
Japanese Journal of Clinical Oncology|February 11, 2026
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case seriesTomoaki Nakamura, Tatsuya Yoshida, Akihiko Yoshida, et al.
Clinical Lung Cancer|June 7, 2017
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After SurgeryShinji Nakamichi, Hidehito Horinouchi, Tetsuhiko Asao, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 23, 2020
Exacerbation of atrioventricular block associated with concomitant use of amlodipine and aprepitant in a lung cancer patient: A case reportHideyuki Hibino, Yoshinori Makino, Naomi Sakiyama, et al.
Clinical Lung Cancer|November 22, 2016
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung CancerHitomi Sumiyoshi Okuma, Hidehito Horinouchi, Shinsuke Kitahara, et al.
International Journal of Clinical Oncology|August 27, 2024
A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutationsKiyotaka Yoh, Koichi Azuma, Hidetoshi Hayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinomaTetsuya Okano, Tadashi Kondo, Kiyonaga Fujii, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2004
Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinibToshimi Takano, Yuichiro Ohe, Masahiko Kusumoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancerYuichiro Ohe, Yukito Ichinose, Kazuhiko Nakagawa, et al.
Pageof 45